E-ISSN 2231-170X | ISSN 2231-1696
 
2023, Vol: 13, Issue: 1
13 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles

Original Article 


Comparison of Tobramycin and Moxifloxacin eye drops in acute bacterial conjunctivitis: An open label randomized controlled institutional study from Kolkata

Prithwijit Banerjee, Mita Saha Dutta Chowdhury, Souradeep Ray, Soumya Chatterjee, Shreshtha Basak, Asoke Kumar Das.

Abstract
Topical antibiotics are used empirically to hasten the clinical cure and prevent transmission. Tobramycin and Moxifloxacin eye drops are frequently prescribed but head to head clinical comparison was not documented from eastern India. This study was aimed to compare the efficacy and safety of both antibiotics in suspected acute bacterial conjunctivitis. This study was conducted from February 2019 to May 2019. 150 patients with suspected bacterial conjunctivitis were randomized into two groups to receive either Tobramycin sulphate 0.3% W/V or Moxifloxacin 0.5% W/V eye drops 4 times daily in the effected eye for a period of seven days in an open label manner. All participants were allowed to simultaneously apply tear substitute (Carboxymethylcellulose sodium 0.5% W/V) in both eyes thrice daily. Efficacy was measured on day 3 and 7 in terms of clinical cure rate which was defined as absence of any eye sign of conjunctivitis. Safety of the drugs was assessed by the overall ocular adverse events reported by the patients. 61 patients from Tobramycin group and 66 from Moxifloxacin group completed the full study. High clinical cure rates were achieved with both agents although it was slightly higher with Moxifloxacin on day 3 (56.06% versus 47.54%; p=0.37) as well as on day 7 (93.94% versus 88.52%; p=0.52) of follow up. A single case of slight blurring of vision was reported with Tobramycin, while another patient complained of mild irritation on eyes from Moxifloxacin group. Overall ocular adverse effects were very mild and comparable. Both Tobramycin sulphate 0.3% W/V and Moxifloxacin 0.5% W/V eye drops are equally effective as empirical therapy when used in acute bacterial conjunctivitis for seven days four times daily with causing negligible side effects.

Key words: Bacterial conjunctivitis, Tobramycin, Moxifloxacin


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Prithwijit Banerjee
Articles by Mita Saha Dutta Chowdhury
Articles by Souradeep Ray
Articles by Soumya Chatterjee
Articles by Shreshtha Basak
Articles by Asoke Kumar Das
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Banerjee P, Chowdhury MSD, Ray S, Chatterjee S, Basak S, Das AK. Comparison of Tobramycin and Moxifloxacin eye drops in acute bacterial conjunctivitis: An open label randomized controlled institutional study from Kolkata. J Med Allied Sci. 2020; 10(2): 110-114. doi:10.5455/jmas.111700

Web Style

Banerjee P, Chowdhury MSD, Ray S, Chatterjee S, Basak S, Das AK. Comparison of Tobramycin and Moxifloxacin eye drops in acute bacterial conjunctivitis: An open label randomized controlled institutional study from Kolkata. https://jmas.in/?mno=111700 [Access: December 05, 2023]. doi:10.5455/jmas.111700

AMA (American Medical Association) Style

Banerjee P, Chowdhury MSD, Ray S, Chatterjee S, Basak S, Das AK. Comparison of Tobramycin and Moxifloxacin eye drops in acute bacterial conjunctivitis: An open label randomized controlled institutional study from Kolkata. J Med Allied Sci. 2020; 10(2): 110-114. doi:10.5455/jmas.111700


Vancouver/ICMJE Style

Banerjee P, Chowdhury MSD, Ray S, Chatterjee S, Basak S, Das AK. Comparison of Tobramycin and Moxifloxacin eye drops in acute bacterial conjunctivitis: An open label randomized controlled institutional study from Kolkata. J Med Allied Sci. (2020), [cited December 05, 2023]; 10(2): 110-114. doi:10.5455/jmas.111700


Harvard Style

Banerjee, P., Chowdhury, . M. S. D., Ray, . S., Chatterjee, . S., Basak, . S. & Das, . A. K. (2020) Comparison of Tobramycin and Moxifloxacin eye drops in acute bacterial conjunctivitis: An open label randomized controlled institutional study from Kolkata. J Med Allied Sci, 10 (2), 110-114. doi:10.5455/jmas.111700


Turabian Style

Banerjee, Prithwijit, Mita Saha Dutta Chowdhury, Souradeep Ray, Soumya Chatterjee, Shreshtha Basak, and Asoke Kumar Das. 2020. Comparison of Tobramycin and Moxifloxacin eye drops in acute bacterial conjunctivitis: An open label randomized controlled institutional study from Kolkata. Journal of Medical and Allied Sciences, 10 (2), 110-114. doi:10.5455/jmas.111700


Chicago Style

Banerjee, Prithwijit, Mita Saha Dutta Chowdhury, Souradeep Ray, Soumya Chatterjee, Shreshtha Basak, and Asoke Kumar Das. "Comparison of Tobramycin and Moxifloxacin eye drops in acute bacterial conjunctivitis: An open label randomized controlled institutional study from Kolkata." Journal of Medical and Allied Sciences 10 (2020), 110-114. doi:10.5455/jmas.111700


MLA (The Modern Language Association) Style

Banerjee, Prithwijit, Mita Saha Dutta Chowdhury, Souradeep Ray, Soumya Chatterjee, Shreshtha Basak, and Asoke Kumar Das. "Comparison of Tobramycin and Moxifloxacin eye drops in acute bacterial conjunctivitis: An open label randomized controlled institutional study from Kolkata." Journal of Medical and Allied Sciences 10.2 (2020), 110-114. Print. doi:10.5455/jmas.111700


APA (American Psychological Association) Style

Banerjee, P., Chowdhury, . M. S. D., Ray, . S., Chatterjee, . S., Basak, . S. & Das, . A. K. (2020) Comparison of Tobramycin and Moxifloxacin eye drops in acute bacterial conjunctivitis: An open label randomized controlled institutional study from Kolkata. Journal of Medical and Allied Sciences, 10 (2), 110-114. doi:10.5455/jmas.111700


Author LoginReviewer LoginAbout PublisherEditorial Review PolicyEditorial & Peer Review ProcessConflict of Interest PolicyAdvertising PolicyLicense InformationCopyright Information

About Journal of Medical and Allied Sciences

Welcome to the Journal of Medical and Allied Sciences (JMAS), an official international publication of Deccan College of Medical Sciences, for rapid publi ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


By regular mail/speed post/courier

Dr. Kazi Mudabbir Ahmed
Editor, JMAS,
Deccan College of Medical Sciences,
DMRL ‘X’ Road, Kanchanbagh (PO),
Hyderabad-500 058, Telangana, India.

By email: editorialoffice@jmas.in

By phone: +91 40 24340225, 24340129

By Mobile: +91-8522828349

By fax: +91 40 24340235